Robert Sommer, MD
Adult Congenital Heart Disease · New York, NYNPI 1316954514
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. W. L. Gore & Associates, Inc. accounts for 82.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $31,172 and has fallen 75.0% since, to $7,797 in 2025.
Across 98 payments — averaging $838.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$68K
- Abbott$8K
- Boston Scientific$5K
- Biosense Webster, Inc.$1K
- Boehringer Ingelheim$114
- Pfizer$38
- plus $59 from 3 others
Across 154 payments — averaging $5795.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- W. L. Gore & Associates, Inc.$518K
- Abbott$136K
- Edwards Lifesciences$121K
- Boston Scientific$108K
- Biosense Webster, Inc.$9K
What the payments were for
- Consulting fees$43,21353%
- Speaking & faculty fees$30,08537%
- Travel & lodging$4,7146%
- Food & beverage$4,1605%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 40 | $67,663 |
| Abbott | 19 | $7,904 |
| Boston Scientific | 23 | $5,196 |
| Biosense Webster, Inc. | 6 | $1,196 |
| Boehringer Ingelheim | 6 | $114 |
| Pfizer | 1 | $38 |
| Heartflow, Inc. | 1 | $24 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $18 |
| Amgen | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GORE CARDIOFORM Septal Occluder$56,916
- CARDIOFORM Septal Occluder$10,238
- AMPLATZER TALISMAN$7,417
- Watchman$4,112
- Thermocool SF$1,143
- WATCHMAN Access System$475
- AMPLATZER$288
- LUX-Dx Insertable Cardiac Monitor$151
How this compares
Too few adult congenital heart disease providers in New Yorkto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other adult congenital heart disease in New York
- Harsimran SinghNew York$10K
- Jonathan KochavNew York$1K
- Noa Zemer WassercugNew York$983
- Yamini KrishnamurthyNew York$871
- Su YuanNew York$602
- Kali HopkinsNew York$494
- Eihab GhantousNew York$358
- Adam SmallNew York$322
- Matthew LewisNew York$69
- Emily SlaterNew York$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.